Picture of Jenscare Scientific Co logo

9877 Jenscare Scientific Co Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+1.9%
3m+27.95%
6m+93.68%
1yr-50.99%
Volume Change (%)
10d/3m-73.46%
Price vs... (%)
52w High-57.04%
50d MA+2.95%
200d MA+26.89%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-28.24%
Return on Equity-24.49%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Jenscare Scientific Co EPS forecast chart

Profile Summary

Jenscare Scientific Co Ltd is a China-based company mainly engaged in the research and development of interventional products for the treatment of structural heart diseases and other related medical products. The Company develops a series of treatment solutions targeting different types of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, heart failure and cardiogenic stroke. The Company's products and pipelines mainly include LuX-Valve, LuX-Valve Plus, Ken-Valve, JensClip, JensRelive, MicroFlux and SimuLock. LuX-Valve is the first-generation transcatheter tricuspid valve replacement system designed to treat patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is the first-generation transcatheter aortic valve replacement system designed to treat patients with severe aortic regurgitation or combined with aortic stenosis.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    June 30th, 2024
    Incorporated
    November 8th, 2011
    Public Since
    October 10th, 2022
    No. of Employees
    241
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    hk flag iconStock Exchange of Hong Kong Limited
    Shares in Issue
    417,167,290
    Blurred out image of a map
    Address
    Block 5, B Area,, NINGBO
    Web
    https://www.jenscare.com/
    Phone
    Auditors
    Ernst & Young

    9877 Share Price Performance

    Upcoming Events for 9877

    Jenscare Scientific Co Ltd Annual Shareholders Meeting

    Similar to 9877

    Picture of Acotec Scientific Holdings logo

    Acotec Scientific Holdings

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Beijing Airdoc Technology Co logo

    Beijing Airdoc Technology Co

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of AK Medical Holdings logo

    AK Medical Holdings

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of AMCO United Holding logo

    AMCO United Holding

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Angelalign Technology logo

    Angelalign Technology

    hk flag iconStock Exchange of Hong Kong Limited

    FAQ